84 related articles for article (PubMed ID: 31875147)
1. Evaluation of human-papillomavirus screening for cervical cancer in China's rural population.
Li L; Zheng Z; Li L
PeerJ; 2019; 7():e8152. PubMed ID: 31875147
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of triage strategies for high-risk human papillomavirus-positive women in cervical cancer screening: A multicenter randomized controlled trial in different resource settings in China.
Dang L; Kong L; Zhao Y; Dai Y; Ma L; Wei L; Zhang S; Liu J; Xi M; Chen L; Duan X; Xiao Q; Abulizi G; Zhang G; Hong Y; Zhou Q; Xie X; Li L; Niyazi M; Zhang Z; Tuo J; Ding Y; Qiao Y; Lang J
Chin J Cancer Res; 2022 Oct; 34(5):496-509. PubMed ID: 36398123
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
[TBL] [Abstract][Full Text] [Related]
5. [Cost-effectiveness analysis on the once-in-a-lifetime cervical cancer screening program for women living in rural and urban areas of China].
Xu H; Zhao FH; Gao XH; Hu SY; Chen JF; Liu ZH; Xu XL; Gao LM; Liu QG; Ma L; Liu YJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Apr; 34(4):399-403. PubMed ID: 23937850
[TBL] [Abstract][Full Text] [Related]
6. Performance of cervical cancer screening and triage strategies among women living with HIV in China.
Duan R; Zhao X; Zhang H; Xu X; Huang L; Wu A; Li L; Qiao Y; Zhao F
Cancer Med; 2021 Sep; 10(17):6078-6088. PubMed ID: 34342174
[TBL] [Abstract][Full Text] [Related]
7. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
8. Comparative accuracy of Pap smear and HPV screening in Ubon Ratchathani in Thailand.
Sangrajrang S; Laowahutanont P; Wongsena M; Muwonge R; Karalak A; Imsamran W; Senkomago V; Sankaranarayanan R
Papillomavirus Res; 2017 Jun; 3():30-35. PubMed ID: 28720454
[TBL] [Abstract][Full Text] [Related]
9. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
10. HPV self-testing for primary cervical cancer screening in Madagascar: VIA/VILI triage compliance in HPV-positive women.
Benski AC; Viviano M; Jinoro J; Alec M; Catarino R; Herniainasolo J; Vassilakos P; Petignat P
PLoS One; 2019; 14(8):e0220632. PubMed ID: 31408474
[TBL] [Abstract][Full Text] [Related]
11. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
12. Triage of Women Testing Positive With the careHPV Test on Self-Collected Vaginal Samples for Cervical Cancer Screening in a Low-Resource Setting.
Poli UR; Gowrishankar S; Swain M; Jeronimo J
J Glob Oncol; 2018 Sep; 4():1-7. PubMed ID: 30241206
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of effectiveness of Pap smear versus visual inspection with acetic acid and visual inspection with Lugol's iodine for mass screening of premalignant and malignant lesion of cervix.
Consul S; Agrawal A; Sharma H; Bansal A; Gutch M; Jain N
Indian J Med Paediatr Oncol; 2012 Jul; 33(3):161-5. PubMed ID: 23248422
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of human Papillomavirus detected among women positive for cervical lesions by visual inspection with acetic acid/Lugol's iodine (VIA/VILI) in Libreville, Gabon.
Moussavou PB; Koumakpayi IH; Nkili-Meyong AA; Labouba I; Bisvigou U; Chansi JK; Engohan-Aloghe C; Dissanami F; Ambounda N; Delannoy-Vieillard AS; Diancourt L; Nkoghe D; Leroy EM; Belembaogo E; Berthet N
Infect Agent Cancer; 2016; 11(1):50. PubMed ID: 27610192
[TBL] [Abstract][Full Text] [Related]
16. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
[No Abstract] [Full Text] [Related]
17. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings: A cross-sectional study in China.
Wang M; Hu S; Zhao S; Zhang W; Pan Q; Zhang X; Chen F; Han J; Ma J; Smith JS; Qiao Y; Zhou C; Zhao F
Chin J Cancer Res; 2017 Dec; 29(6):496-509. PubMed ID: 29353972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
